LumiraDx Limited (LMDXF)
OTCMKTS · Delayed Price · Currency is USD
0.0100
+0.0090 (900.00%)
Inactive · Last trade price on Oct 25, 2024
Verve Therapeutics Revenue
LumiraDx had revenue of $21.00M in the quarter ending June 30, 2023, a decrease of -53.04%. This brings the company's revenue in the last twelve months to $126.52M, down -68.25% year-over-year. In the year 2022, LumiraDx had annual revenue of $254.48M, down -39.62%.
Revenue (ttm)
126.52M
Revenue Growth
-68.25%
P/S Ratio
0.02
Revenue / Employee
104.56K
Employees
1,210
Market Cap
3.59M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 254.48M | -166.95M | -39.62% |
Dec 31, 2021 | 421.43M | 282.28M | 202.85% |
Dec 31, 2020 | 139.15M | 116.01M | 501.30% |
Dec 31, 2019 | 23.14M | -2.24M | -8.84% |
Dec 31, 2018 | 25.39M | - | - |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition